Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
JTH Volume 16 - 2018
Share |

Journal of Thrombosis and Haemostasis

Volume 16 (2018)

Makris M, Oldenburg J, Mauser‐Bunschoten EP, Peerlinck K, Castaman G, Fijnvandraat K, for the Subcommittee on Factor VIII, Factor IX and Rare Bleeding Disorders. The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTHJ Thromb Haemost 201816: 2530–3.

Petermann R, Bakchoul T, Curtis BR, Mullier F, Miyata S, Arnold DM, for the Subcommittee on Platelet Immunology. Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTHJ Thromb Haemost 2018; 16: 2526–9.

Frelinger AL III, Gachet C, Mumford AD, Noris P, Mezzano D, Harrison P, Gresele P, for the Subcommittee on Platelet Physiology. Laboratory monitoring of P2Y12 inhibitors: communication from the SSC of the ISTHJ Thromb Haemost2018; 16: 2341–6.

Thomas W, Samama C‐M, Greinacher A, Hunt BJ, for the Subcommittee on Perioperative and Critical Care. The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital‐associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTHJ Thromb Haemost201816: 2336–40.

Mancuso ME, Bidlingmaier C, Mahlangu JN, Carcao M, Tosetto A, for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTHJ Thromb Haemost 2018; 16: 2106–10.

Harrison P, for the Subcommittee on Platelet Physiology. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTHJ Thromb Haemost  2018; 16: 1895–900.

Khorana AA, Noble S, Lee AYY, Soff G, Meyer G, O'Connell C, Carrier M. Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTHJ Thromb Haemost 2018; 16: 1891–4.

Casini A, Undas A, Palla R, Thachil J, de Moerloose P, for the Subcommittee on Factor XIII and Fibrinogen. Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16: 1887–90.

Suzuki K, Wada H, Imai H, Iba T, Thachil J, Toh C‐H, for the Subcommittee on Disseminated Intravascular Coagulation. A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16: 1442–4.

Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A, for the Subcommittee on Factor VIII, Factor IX, and Rare Bleeding Disorders. Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTHJ Thromb Haemost 201816: 1437–41.

van der Pol E, Sturk A, van Leeuwen T, Nieuwland R, Coumans F, for the ISTH‐SSC‐VB Working group. Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximationJ Thromb Haemost 2018; 16: 1236–1245.

Samuelson Bannow BT, Lee A, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M. Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTHJ Thromb Haemost 2018; 16: 1246–1249.

Pieters M, Philippou H, Undas A, de Lange Z, Rijken DC, Mutch NJ, for the Subcommittee on Factor XIII and Fibrinogen, and the Subcommittee on Fibrinolysis. An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTHJ Thromb Haemost 2018; 16: 1007–12.

Thelwell C, Rigsby P, Locke M, Bevan S, Longstaff C. An international collaborative study to calibrate the WHO 2nd International Standard for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin (15/140): communication from the SSC of the ISTHJ Thromb Haemost 2018; 16: 1003–6.

Devreese KMJ, Ortel TL, Pengo V, de Laat B, for the Subcommittee on Lupus Anticoagulant/Antiphospholip ID Antibodies. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16: 809–13. 

Biss TTRajpurkar MWilliams Svan Ommen CHChan AKCGoldenberg NAfor the Subcommittee on Pediatric and Neonatal Thrombosis and HemostasisRecommendations for future research in relation to pediatric pulmonary embolism: communication from the SSC of the ISTHJ Thromb Haemost 2018164058.

Tullius BPAthale Uvan Ommen CHChan AKCPalumbo JSBalagtas JMSfor the Subcommittee on Hemostasis and Malignancy and the Subcommittee on Pediatric/Neonatal Thrombosis and HemostasisThe identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTHJ Thromb Haemost 20181617580.

Godier AGreinacher AFaraoni DLevy JHSamama CMUse of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTHJ Thromb Haemost 2018161704.

van den Besselaar AMHP, Chantarangkul V, Angeloni F, Binder NB, Byrne M, Dauer R, Gudmundsdottir BR, Jespersen J, Kitchen S, Legnani C, Lindahl TL, Manning RA, Martinuzzo M, Panes O, Pengo V, Riddell A, Subramanian S, Szederjesi A, Tantanate C, Herbel P, Tripodi A. International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plainJ Thromb Haemost 2018; 16: 142–9.

 

 

Membership Management Software Powered by YourMembership  ::  Legal